Operating Principle: The Devyser CFTR NGS kit redefines the genetic diagnosis of cystic fibrosis by offering a comprehensive and precise solution, validated for clinical use. With a unique single-tube library preparation approach, this kit optimizes the CFTR gene analysis process, significantly reducing hands-on time and contamination risk while improving diagnostic accuracy.

Clinical Applications

Advances in NGS techniques allow laboratories to perform a comprehensive diagnosis by analyzing the entire CFTR gene, covering known and novel variants. The integrated analysis software, along with databases such as CFTR2, ensures that variants are classified with high reliability.

Benefits

High efficiency and optimal performance: A single tube per sample minimizes the risk of pre-analytical errors and contamination. Ease of use: <45 minutes of hands-on time and a total turnaround time of less than 5 hours, accelerating diagnostic turnaround times. Broad coverage including:
All exonic regions of the gene + a minimum of 20 bp at the 5′ end and 10 bp at the 3′ end of the exon/intron junctions. Promoter region. Clinically relevant deep intronic variants.
Complete solution: Allows the analysis of SNVs and indels, as well as CNVs and identification of specific variants such as poly-T and TG repeats. Adaptability: Integration with validated analysis software increases flexibility for laboratories with different needs. Compatible with DNA samples extracted from peripheral blood and dried blood spots.
Devyser CFTR for NGS

Technology Used

Multiplex PCR technology with targeted enrichment and subsequent library preparation for NGS workflows. The indices added to the samples come pre-dispensed in strip or plate format, minimizing the risk of contamination. Furthermore, the process includes a post-pooling library cleanup for all samples. The entire workflow is CE-IVD validated and supported by validated software solutions, including CNV analysis, enabling you to obtain precise and reliable results.

Intended Audience/User

Ideal for genetics and molecular biology laboratories requiring comprehensive and reliable analysis of the CFTR gene, especially in newborn screening programs, prenatal testing, and genetic counseling.

Key Features

Comprehensive coverage of the CFTR gene, including deep intronic variants and the promoter region.
Direct detection of CNVs and identification of poly-T variants and TG repeats.
Standardized and validated CE-IVD workflow.
Less than 45 minutes of hands-on time.
Minimal risk of sample mix-ups or contamination.
Compatible with validated bioinformatics analysis software.

Ordering Information

CE-IVD Devyser CFTR Kits
8-A101-8 8 tests
8-A101-24 24 tests
8-A101-96 96 tests
RUO Devyser CFTR Kits
8-A103-8 8 tests
8-A103-24 24 tests
8-A103-96 96 tests
Accessories
8-A200 Devyser Index Plate A
8-A204 Devyser Library Clean

Area:

Cystic fibrosis, Molecular Genetics, Targeted study of specific pathologies

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)